Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes by Ethnicity and Race-ONWARDS 1-5

被引:0
|
作者
Lingvay, Ildiko
Bangsgaard, Katrine O.
Desouza, Cyrus
Marques, Mariana Fragao
Navarria, Andrea, Sr.
Vianna, Andre G.
机构
关键词
D O I
10.2337/db24-841-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
841-P
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Impact of Age on the Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Insulin in Type 2 Diabetes (ONWARDS 1-5)
    Vianna, Andre G. D.
    Desouza, Cyrus
    Laugesen, Christian
    Marques, Mariana Fragao
    Nielsen, Pernille Hojlund
    Shaikh, Shehla S.
    Lingvay, Ildiko
    [J]. DIABETES, 2024, 73
  • [2] Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Individuals with Type 2 Diabetes by Kidney Function-ONWARDS 1-5
    Rossing, Peter
    Benamar, Malik
    Cheng, Alice Y. Y.
    Laugesen, Christian
    Nielsen, Pernille Hojlund
    Bajaj, Harpreet S.
    [J]. DIABETES, 2024, 73
  • [3] Efficacy and safety of once-weekly insulin icodec versus once-daily insulin degludec in type 1 diabetes: ONWARDS 6
    Russell-Jones, D.
    Babazono, T.
    Cailleteau, R.
    Engberg, S.
    Irace, C.
    Kjaersgaard, M. I. S.
    Mathieu, C.
    Rosenstock, J.
    Woo, V.
    Klonoff, D. C.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S7 - S8
  • [4] No Evidence of Increased Physical Activity-Related Hypoglycemia with Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes-ONWARDS 1-5
    Riddell, Michael C.
    Heller, Simon R.
    Asong, Marisse
    Carstensen, Lisbeth
    Watt, Sara K.
    Woo, Vincent C.
    [J]. DIABETES, 2024, 73
  • [5] Efficacy and Safety of Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 2 Diabetes according to Baseline Glucagon-Like Peptide 1 Receptor Agonist Use-ONWARDS 1-5
    Vilsboll, Tina
    Bangsgaard, Katrine O.
    Fu, Ariel
    Kellerer, Monika
    Sogaard, Stinne B.
    Goldenberg, Ronald
    [J]. DIABETES, 2024, 73
  • [6] Better Glycemic Control with Once-Weekly Insulin Icodec vs. Once-Daily Insulin Degludec in Insulin-Naive Type 2 Diabetes (ONWARDS 3)
    Lingvay, Ildiko
    Asong, Marisse
    Desouza, Cyrus
    Gourdy, Pierre
    Kar, Soumitra
    Vianna, Andre G.
    Vilsboll, Tina
    Vinther, Siri M.
    Mu, Yiming
    [J]. DIABETES, 2023, 72
  • [7] No Evidence of Increased Physical Activity-Related Hypoglycemia with Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 1 Diabetes-ONWARDS 6
    Sourij, Harald
    Bracken, Richard M.
    Asong, Marisse
    Carstensen, Lisbeth
    Watt, Sara K.
    Philis-Tsimikas, Athena
    [J]. DIABETES, 2024, 73
  • [8] Improved glycaemic control with once-weekly insulin icodec with a dosing guide app vs once-daily basal insulin analogues in insulin-naive type 2 diabetes: ONWARDS 5
    Bajaj, H. S.
    Aberle, J.
    Davies, M.
    Donatsky, A. M.
    Frederiksen, M.
    Yavuz, D. G.
    Gowda, A.
    Lingvay, I.
    Bode, B.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S398 - S399
  • [9] Improved treatment satisfaction with once-weekly insulin icodec versus once-daily insulin degludec in basal insulin-treated type 2 diabetes (ONWARDS 2)
    Polonsky, W.
    Benamar, M.
    Carstensen, L.
    Davies, M.
    Donatsky, A. M.
    Franek, E.
    Kellerer, M.
    Goldenberg, R.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S400 - S400
  • [10] Efficacy and Safety Outcomes with Once-Weekly Insulin Icodec vs. Once-Daily Insulin Degludec in Type 1 Diabetes According to Glycemic Variability-ONWARDS 6 Post Hoc Analysis
    Irace, Concetta
    Begtrup, Kamilla
    Marques, Mariana Fragao
    Watt, Sara K.
    Klonoff, David C.
    [J]. DIABETES, 2024, 73